Table 3. Associations Between Blood Pressure Measures and Incident Stroke in Men, Including Participants in Receipt of Baseline Antihypertensive Medication.
Europeans |
South Asians |
|||||
---|---|---|---|---|---|---|
BP Measure | Model Factors | OR | 95% CI | OR | 95% CI | P Value* |
SBP | Age | 1.32 | 1.11–1.57† | 1.61 | 1.35–1.92‡ | 0.16 |
Age+CVD risk factors§ | 1.31 | 1.08–1.58† | 1.52 | 1.25–1.86‡ | 0.16 | |
DBP | Age | 1.01 | 0.85–1.21 | 1.55 | 1.28–1.80‡ | 0.001 |
Age+CVD risk factors§ | 1.02 | 0.83–1.24 | 1.53 | 1.23–1.89‡ | 0.002 | |
MAP | Age | 1.15 | 0.97–1.38 | 1.64 | 1.36–1.97‡ | 0.009 |
Age+CVD risk factors§ | 1.16 | 0.95–1.41 | 1.58 | 1.29–1.95‡ | 0.01 | |
PP | Age | 1.44 | 1.21–1.70‡ | 1.39 | 1.17–1.66‡ | 0.61 |
Age+CVD risk factors§ | 1.40 | 1.16–1.67‡ | 1.29 | 1.06–1.57∥ | 0.69 |
A correction of +10/5 mm Hg was added to the blood pressure of participants in receipt of antihypertensive medication. Data are OR for a 1 SD increase in BP measure unless otherwise stated. CI indicates confidence interval; CVD, cardiovascular disease; DBP, diastolic blood pressure; MAP, mean arterial pressure; OR, odds ratio; PP, pulse pressure; and SBP, systolic blood pressure.
P for ethnicity×BP interaction.
P<0.01.
P<0.001.
CVD risk factors comprise: smoking, waist/hip ratio, total/high-density lipoprotein-cholesterol ratio, diabetes mellitus, fasting glucose, physical activity, and heart rate.
P<0.05.